Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PreveCeutical MedicalPRVCF -4.69% Days Sales Outstanding is 0.00 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 836 Biotechnology companies, PreveCeutical Medical ranks worse than 119617.11% on this metric.
The historical rank and industry rank for PreveCeutical Medical's Days Sales Outstanding or its related term are showing as below:
During the past 11 years, PreveCeutical Medical's highest Days Sales Outstanding was 10585.00. The lowest was 671.93. And the median was 1898.00.
PRVCF's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 69.09 * Ranked among companies with meaningful Days Sales Outstanding only.
PreveCeutical Medical's Days Sales Outstanding
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
PreveCeutical Medical (OTCPK:PRVCF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
PreveCeutical Medical Days Sales Outstanding Related Terms
PreveCeutical Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for PreveCeutical Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PreveCeutical Medical Days Sales Outstanding Chart
PRVCF vs VRTX, REGN, RVMD: Days Sales Outstanding Comparison
For the Biotechnology subindustry, PreveCeutical Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PreveCeutical Medical Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where PreveCeutical Medical's Days Sales Outstanding falls into.
PreveCeutical Medical Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PreveCeutical Medical (PRVCF) has a Days Sales Outstanding of 0.00 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PreveCeutical Medical and its competitors. Over the past decade, PreveCeutical Medical's Days Sales Outstanding has ranged from 671.93 to 10,585.00. According to the industry distribution chart, PreveCeutical Medical ranks #999999 out of 836 companies in the Biotechnology industry.
Is PreveCeutical Medical's Days Sales Outstanding too high?
PreveCeutical Medical's current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 671.93 to a high of 10,585.00. Based on the distribution chart, PreveCeutical Medical ranks #999999 out of 836 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PreveCeutical Medical's Days Sales Outstanding compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PreveCeutical Medical ranks #999999 out of 836 companies for Days Sales Outstanding. This places PreveCeutical Medical in the lower half of its industry. The industry median Days Sales Outstanding is 69.09. Historically, PreveCeutical Medical's own Days Sales Outstanding has ranged from 671.93 to 10,585.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 69.09, based on 836 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PreveCeutical Medical and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 69.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PreveCeutical Medical's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PreveCeutical Medical stock overvalued right now?
PreveCeutical Medical (PRVCF) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For PreveCeutical Medical (PRVCF), the current Days Sales Outstanding is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVCF has been successfully added to your 
